A phase II study of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results

被引：1
|
作者：
Kim, W. Y. [1 ]
Grigson, G. I. [1 ]
Wallen, E. M. [1 ]
Pruthi, R. S. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.11076
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11076
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Smith, Angela
    Coward, Matthew
    Kim, William
    Nielsen, Matthew
    Wallen, Eric
    Pruthi, Raj S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S129 - S129
  • [2] A phase II study of neoadjuvant erlotinib (tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Pearson, Matthew
    Nix, Jeffrey
    Kim, William
    Grigson, Gayle
    Wallen, Eric
    Pruthi, Raj S.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 119 - 119
  • [3] A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results
    Pruthi, Raj S.
    Nielsen, Matthew
    Heathcote, Samuel
    Wallen, Eric M.
    Rathmell, W. Kim
    Godley, Paul
    Whang, Young
    Fielding, Julia
    Schultz, Heather
    Grigson, Gayle
    Smith, Angela
    Kim, William
    O'Donnell, Peter H.
    BJU INTERNATIONAL, 2010, 106 (03) : 349 - 356
  • [4] A Phase II Trial of Neoadjuvant Erlotinib in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: Clinical and Pathological Results Editorial Comment
    Wood, David P.
    JOURNAL OF UROLOGY, 2011, 185 (03): : 811 - 812
  • [5] Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.
    Gupta, Shilpa
    Agarwal, Neeraj
    Konety, Badrinath R.
    Weight, Christopher J.
    Thyagarajan, Bharat
    Murugan, Paari J.
    Koopmeiners, Joseph S.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [6] Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
    Pichler, Renate
    Fritz, Josef
    Mari, Andrea
    Cadenar, Anna
    von Deimling, Markus
    Marcq, Gautier
    del Giudice, Francesco
    Leonardo, Costantino
    Bologna, Eugenio
    Mori, Keiichiro
    Tahbaz, Rana
    De Santis, Maria
    Klatte, Tobias
    Erber, Barbara
    Lackner, Felizian
    Kronbichler, Andreas
    Seeber, Andreas
    Fisch, Margit
    Moschini, Marco
    Pradere, Benjamin
    Mertens, Laura S.
    ONCOLOGIST, 2024, 29 (11): : e1511 - e1522
  • [7] Neoadjuvant Therapy before radical Cystectomy for muscle-invasive Bladder Cancer Phase Ib/II Study for Evaluating the neoadjuvant Combination Therapy of Vinflunine with Cisplatin followed by a radical Cystectomy in Patients with muscle-invasive Bladder Cancer (JaNEO) - Study AB 50/15 of the AUO
    Rexer, H.
    Merseburger, A.
    UROLOGE, 2016, 55 (10): : 1366 - 1367
  • [8] Effects of neoadjuvant chemotherapy on pathological parameters and survival in patients undergoing radical cystectomy for muscle-invasive bladder cancer
    Caglayan, Alper
    Akbulut, Ziya
    Atmaca, Ali Fuat
    Altinova, Serkan
    Kilic, Metin
    Balbay, Mevlana Derya
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 623 - 629
  • [9] Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study
    Nitta, Masahiro
    Kuroda, Satoshi
    Nagao, Kentaro
    Higure, Taro
    Zakoji, Hidenori
    Miyakita, Hideshi
    Usui, Yukio
    Hasegawa, Masanori
    Kawamura, Yoshiaki
    Shoji, Sunao
    Miyajima, Akira
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (01) : 73 - 79
  • [10] Muscle-Invasive Bladder Cancer and Radical Cystectomy
    Hakenberg, Oliver W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (01) : 1 - 1
12345